Cited by 685Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

The DOI matches its Crossref record; 125 of the 129 references it cites were found in a registry or an index.

The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder

del Campo, Natalia, Chamberlain, Samuel R., Sahakian, Barbara J., Robbins, Trevor W.·2011·Biological Psychiatry

DOI 10.1016/j.biopsych.2011.02.036

Open this paper in CoChat — free account

Abstract

Through neuromodulatory influences over fronto-striato-cerebellar circuits, dopamine and noradrenaline play important roles in high-level executive functions often reported to be impaired in attention-deficit/hyperactivity disorder (ADHD). Medications used in the treatment of ADHD (including methylphenidate, dextroamphetamine and atomoxetine) act to increase brain catecholamine levels. However, the precise prefrontal cortical and subcortical mechanisms by which these agents exert their therapeutic effects remain to be fully specified. Herein, we review and discuss the present state of knowledge regarding the roles of dopamine (DA) and noradrenaline in the regulation of corticostriatal circuits, with a focus on the molecular neuroimaging literature (both in ADHD patients and in healthy subjects). Recent positron emission tomography evidence has highlighted the utility of quantifying DA markers, at baseline or following drug administration, in striatal subregions governed by differential cortical connectivity. This approach opens the possibility of characterizing the neurobiological underpinnings of ADHD (and associated cognitive dysfunction) and its treatment by targeting specific neural circuits. It is anticipated that the application of refined and novel positron emission tomography methodology will help to disentangle the overlapping and dissociable contributions of DA and noradrenaline in the prefrontal cortex, thereby aiding our understanding of ADHD and facilitating new treatments.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2011.02.036

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inhibition and the right inferior frontal cortex
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.02.010 · Cited by 3,197
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771
Self-citation
Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum
Haber, S. N., Fudge, J. L., & McFarland, N. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02369.2000 · Cited by 1,610
Modulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
On the ability to inhibit simple and choice reaction time responses: A model and a method.
Logan, G. D., Cowan, W. B., & Davis, K. A. (1984) · Journal of Experimental Psychology: Human Perception and Performance · doi:10.1037/0096-1523.10.2.276 · Cited by 1,542
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479
Attention-Deficit/Hyperactivity Disorder: A Selective Overview
Biederman, J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.020 · Cited by 1,343
The role of the right inferior frontal gyrus: inhibition and attentional control
Hampshire, A., Chamberlain, S. R., Monti, M. M., Duncan, J., & Owen, A. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.109 · Cited by 1,327
Self-citation
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study
Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182
Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Functional connectivity of human striatum: a resting state FMRI study
Di Martino, A., Scheres, A., Margulies, D. S., Kelly, A. M. C., Uddin, L. Q., Shehzad, Z., Biswal, B., Walters, J. R., Castellanos, F. X., & Milham, M. P. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn041 · Cited by 1,090
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957
Self-citation
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study
BIEDERMAN, J., MONUTEAUX, M. C., MICK, E., SPENCER, T., WILENS, T. E., SILVA, J. M., SNYDER, L. E., & FARAONE, S. V. (2006) · Psychological Medicine · doi:10.1017/s0033291705006410 · Cited by 850
Neurobiology of attention-deficit hyperactivity disorder
Faraone, S. V., & Biederman, J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00240-6 · Cited by 811
Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications
Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., et al. (2009) · JAMA · doi:10.1001/jama.2009.1308 · Cited by 728 · cited 4×
“2009 (11) [(11)C]cocaine A 53-44 Naïve None Whole brain analysis and template ROIs from the Talairach Daemon database SWAN Decreased DAT in L accumbens, midbrain, CAU and in hypothalamic region.”
BackgroundMethodInfluential
Modafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain
Mehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-j0004.2000 · Cited by 608
A Meta-Analytic Review of Stopping Performance in Attention-Deficit/Hyperactivity Disorder: Deficient Inhibitory Motor Control?
Lijffijt, M., Kenemans, J. L., Verbaten, M. N., & van Engeland, H. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.2.216 · Cited by 592
Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter
Sesack, S. R., Hawrylak, V. A., Matus, C., Guido, M. A., & Levey, A. I. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02697.1998 · Cited by 586
Attention-Deficit Hyperactivity Disorder
Hinshaw, S. P., & Zalecki, C. A. (2001) · Elsevier eBooks · doi:10.1016/b978-008043362-2/50006-8 · Cited by 585
Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks
Eagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548
Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans
Lehéricy, S., Ducros, M., Van De Moortele, P., Francois, C., Thivard, L., Poupon, C., Swindale, N., Ugurbil, K., & Kim, D. (2004) · Annals of Neurology · doi:10.1002/ana.20030 · Cited by 542
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography
Krause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521
Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder
Biederman, J., & Spencer, T. J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00192-4 · Cited by 515
Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets
Sesack, Sr., Aoki, C., & Pickel, V. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00088.1994 · Cited by 461
The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder
Arnsten, A. F. T. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050084013 · Cited by 458
The neuropsychiatry of impulsivity
Chamberlain, S. R., & Sahakian, B. J. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280ba4989 · Cited by 445
Dextroamphetamine: Its Cognitive and Behavioral Effects in Normal and Hyperactive Boys and Normal Men
Rapoport, J. L. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780210091010 · Cited by 434
Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway
Volkow, N. D., Wang, G.-J., Newcorn, J. H., Kollins, S. H., Wigal, T. L., Telang, F., Fowler, J. S., Goldstein, R. Z., Klein, N., Logan, J., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.97 · Cited by 429 · cited 2×
“2010 (27) [(11)C]cocaine A 45-41 Naïve None Accumbens, midbrain MPQ (Achievement scale) Significant correlation between trait motivation and DAT in accumbens and midbrain in ADHD patients but not control subjects.”
Background
Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task
Rubia, K., Halari, R., Cubillo, A., Mohammad, A.-M., Brammer, M., & Taylor, E. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.013 · Cited by 393
Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial
Sallee, F. R., Mcgough, J., Wigal, T., Donahue, J., Lyne, A., & Biederman, J. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318191769e · Cited by 391
Effects of methylphenidate on spatial working memory and planning in healthy young adults
Elliott, R., Sahakian, B. J., Matthews, K., Bannerjea, A., Rimmer, J., & Robbins, T. W. (1997) · Psychopharmacology · doi:10.1007/s002130050284 · Cited by 389
In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs implications for the origin of extracellular DOPAC
Zetterström, T., Sharp, T., Collin, A.-K., & Ungerstedt, U. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90110-0 · Cited by 378
Fundamentals of Attention-Deficit/Hyperactivity Disorder: Circuits and Pathways
Arnsten, A. F. T. (2006) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 378
Mechanism of action of methylphenidate: Insights from PET imaging studies
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s05 · Cited by 353
Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine
Martinez, D., Narendran, R., Foltin, R. W., Slifstein, M., Hwang, D.-R., Broft, A., Huang, Y., Cooper, T. B., Fischman, M. W., Kleber, H. D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.622 · Cited by 351
Neurobiology of Attention Deficit Disorder With Hyperactivity: Where Have We Come in 50 Years?
Zametkin, A. J., & Rapoport, J. L. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198709000-00011 · Cited by 348
Depressed Dopamine Activity in Caudate and Preliminary Evidence of Limbic Involvement in Adults With Attention-Deficit/Hyperactivity Disorder
Volkow, N. D., Wang, G.-J., Newcorn, J., Telang, F., Solanto, M. V., Fowler, J. S., Logan, J., Ma, Y., Schulz, K., Pradhan, K., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.8.932 · Cited by 331
DOPA Decarboxylase Activity in Attention Deficit Hyperactivity Disorder Adults. A [Fluorine-18]Fluorodopa Positron Emission Tomographic Study
Ernst, M., Zametkin, A. J., Matochik, J. A., Jons, P. H., & Cohen, R. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05901.1998 · Cited by 320
Atomoxetine Modulates Right Inferior Frontal Activation During Inhibitory Control: A Pharmacological Functional Magnetic Resonance Imaging Study
Chamberlain, S. R., Hampshire, A., Müller, U., Rubia, K., del Campo, N., Craig, K. J., Regenthal, R., Suckling, J., Roiser, J. P., Grant, J. E., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.014 · Cited by 313
Connectivity-based segregation of the human striatum predicts personality characteristics
Cohen, M. X., Schoene-Bake, J.-C., Elger, C., & Weber, B. (2009) · Nature Neuroscience · doi:10.1038/nn.2228 · Cited by 303
Effects of dextroamphetamine on cognitive performance and cortical activation
Mattay, V. S., Callicott, J. H., Bertolino, A., Heaton, I., Frank, J. A., Coppola, R., Berman, K. F., Goldberg, T. E., & Weinberger, D. R. (2000) · NeuroImage · doi:10.1006/nimg.2000.0610 · Cited by 296
L-dopa modulates functional connectivity in striatal cognitive and motor networks: A double-blind placebo-controlled study
Kelly, C., de Zubicaray, G., Di Martino, A., Copland, D. A., Reiss, P. T., Klein, D. F., Castellanos, F. X., Milham, M. P., & McMahon, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0810-09.2009 · Cited by 292
Stimulant drugs and vigilance performance: a review
Koelega, H. S. (1993) · Psychopharmacology · doi:10.1007/bf02257400 · Cited by 285
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment
Dresel, S., Krause, J., Krause, K.-H., LaFougere, C., Brinkbäumer, K., Kung, H. F., Hahn, K., & Tatsch, K. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000330 · Cited by 278
Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder
Wilens, T. E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173312f · Cited by 269
Methylphenidate improves working memory and set‐shifting in AD/HD: relationships to baseline memory capacity
Mehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00221.x · Cited by 258
Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.
van Dyck, C. H., Malison, R. T., Jacobsen, L. K., Seibyl, J. P., Staley, J. K., Laruelle, M. A., Baldwin, R. M., Innis, R. B., & Gelernter, J. E. (2005) · PubMed · Cited by 257
High Midbrain [ 18 F]DOPA Accumulation in Children With Attention Deficit Hyperactivity Disorder
Ernst, M., Zametkin, A. J., Matochik, J. A., Pascualvaca, D., Jons, P. H., & Cohen, R. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1209 · Cited by 256
Age-Related Decline in Dopamine Transporters: Analysis of Striatal Subregions, Nonlinear Effects, and Hemispheric Asymmetries
van Dyck, C. H., Seibyl, J. P., Malison, R. T., Laruelle, M. A., Zoghbi, S. S., Baldwin, R. M., & Innis, R. B. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00005 · Cited by 251
Brain dopamine transporter levels in treatment and drug naive adults with ADHD
Volkow, N. D., Wang, G.-J., Newcorn, J., Fowler, J. S., Telang, F., Solanto, M. V., Logan, J., Wong, C., Ma, Y., Swanson, J. M., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.014 · Cited by 249
Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity
Jucaite, A., Fernell, E., Halldin, C., Forssberg, H., & Farde, L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.009 · Cited by 236
Clinically Relevant Doses of Methylphenidate Significantly Occupy Norepinephrine Transporters in Humans In Vivo
Hannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236
Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory
Clatworthy, P. L., Lewis, S. J. G., Brichard, L., Hong, Y. T., Izquierdo, D., Clark, L., Cools, R., Aigbirhio, F. I., Baron, J.-C., Fryer, T. D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3266-08.2009 · Cited by 229
Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1147 · Cited by 228
Central α1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals
Duteil, J., Rambert, F. A., Pessonnier, J., Hermant, J.-F., Gombert, R., & Assous, E. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90591-s · Cited by 220
Correspondence
Mercuri, N. B., Saiardi, A., Bonci, A., Picetti, R., Calabresi, P., Bernardi, G., & Borrelli, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00135-8 · Cited by 198
Homeostatic Sleep Pressure and Responses to Sustained Attention in the Suprachiasmatic Area
Schmidt, C., Collette, F., Leclercq, Y., Virginie Sterpenich, A., Vandewalle, G., Berthomier, P., Berthomier, C., Phillips, C. L. M., Tinguely, G., Darsaud, A., et al. (2009) · Science · doi:10.1126/science.1167337 · Cited by 198
Modafinil Shifts Human Locus Coeruleus to Low-Tonic, High-Phasic Activity During Functional MRI
Minzenberg, M., Watrous, A. J., Yoon, J. H., Ursu, S., & Carter, C. S. (2008) · Science · doi:10.1126/science.1164908 · Cited by 198
Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats
Bari, A., Eagle, D. M., Mar, A. C., Robinson, E. S. J., & Robbins, T. W. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1537-0 · Cited by 194
Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder
Cheon, K.-A. A., Ryu, Y. H., Kim, Y.-K., Namkoong, K., Kim, C., & Lee, J. E. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1047-3 · Cited by 189
In Vivo Neuroreceptor Imaging in Attention-Deficit/Hyperactivity Disorder: A Focus on The Dopamine Transporter
Spencer, T. J., Biederman, J., Madras, B. K., Faraone, S. V., Dougherty, D. D., Bonab, A. A., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.036 · Cited by 185
Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery
Chamberlain, S. R., Robbins, T. W., Winder-Rhodes, S., Müller, U., Sahakian, B. J., Blackwell, A. D., & Barnett, J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.019 · Cited by 178
“Paradoxical” effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology
Robbins, T. W., & Sahakian, B. J. (1979) · Neuropharmacology · doi:10.1016/0028-3908(79)90157-6 · Cited by 170 · cited 2×
“A growing body f evidence suggests that psychostimulants exert their theraeutic effects in a baseline-dependent manner, according to a ypothesized inverted U-shaped function (48,50).”
Background
PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[11C]O-methylreboxetine and HRRT
Ding, Y., Singhal, T., Planeta‐Wilson, B., Gallezot, J., Nabulsi, N., Labaree, D. C., Ropchan, J. R., Henry, S. E., Williams, W. A., Carson, R. E., et al. (2009) · Synapse · doi:10.1002/syn.20696 · Cited by 169
High Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers
Salokangas, R. K. R., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvã«¡hti, E., & Hietala, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.632 · Cited by 164 · cited 1×
“SPECT) and radiotracer have an impact on DA marker estimates (7), factors such as age (22), previous drug or nicotine exposure (23,24), and regular psychostimulant treatment (25) have a known influence on the expression of dopaminergic markers and yet have not always been controlled for.”
Background
The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate
Cheon, K.-A. A., Ryu, Y. H., Kim, J.-W., & Cho, D.-Y. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.004 · Cited by 162
Psychostimulants as cognitive enhancers: The prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder
Berridge, C. W., & Devilbiss, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.023 · Cited by 160
d-Amphetamine-Induced Inhibition of Central Dopaminergic Neurons: Mediation by a Striato-Nigral Feedback Pathway
Bunney, B. S., & Achajanian, G. K. (1976) · Science · doi:10.1126/science.1257777 · Cited by 154
Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane
Spencer, T. J., Biederman, J., Madras, B. K., Dougherty, D. D., Bonab, A. A., Livni, E., Meltzer, P. C., Martin, J., Rauch, S., & Fischman, A. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.008 · Cited by 150
A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Greenhill, L. L., Biederman, J., Boellner, S. W., Rugino, T. A., Sangal, R. B., Earl, C. Q., JIANG, J. G., & Swanson, J. M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000205709.63571.c9 · Cited by 145
Dysfunctions in Dopamine Systems and ADHD: Evidence From Animals and Modeling
Viggiano, D., Vallone, D., & Sadile, A. G. (2004) · Neural Plasticity · doi:10.1155/np.2004.97 · Cited by 143
Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder
van Dyck, C. H., Quinlan, D. M., Cretella, L. M., Staley, J. K., Malison, R. T., Baldwin, R. M., Seibyl, J. P., & Innis, R. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.309 · Cited by 139
Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder
Rosa-Neto, P., Lou, H. C., Cumming, P., Pryds, O., Karrebaek, H., Lunding, J., & Gjedde, A. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.11.031 · Cited by 135
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans
Riccardi, P., Li, R., Ansari, M. S., Zald, D., Park, S., Dawant, B., Anderson, S., Doop, M., Woodward, N., Schoenberg, E., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300916 · Cited by 134
Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder
Turner, D. C., Blackwell, A. D., Dowson, J. H., McLean, A., & Sahakian, B. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1993-5 · Cited by 127
Methylphenidate Down-Regulates the Dopamine Receptor and Transporter System in Children with Attention Deficit Hyperkinetic Disorder (ADHD)
Vles, J. S. H., FERON, F. J. M., Hendriksen, J. G. M., Jolles, J., van Kroonenburgh, M. J. P. G., & Weber, W. E. J. (2003) · Neuropediatrics · doi:10.1055/s-2003-39602 · Cited by 122
Dysregulation of Dopamine Transporters via Dopamine D 2 Autoreceptors Triggers Anomalous Dopamine Efflux Associated with Attention-Deficit Hyperactivity Disorder
Bowton, E., Saunders, C., Erreger, K., Sakrikar, D. S., Matthies, H. J. G., Sen, N., Jessen, T. N., Colbran, R. J., Caron, M. G., Javitch, J. A., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5094-09.2010 · Cited by 121
Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride
Slifstein, M., Kegeles, L. S., Xu, X., Thompson, J. L., Urban, N., Castrillon, J., Hackett, E., Bae, S. ‐., Laruelle, M., & Abi‐Dargham, A. (2010) · Synapse · doi:10.1002/syn.20734 · Cited by 115
Acute neuropsychological effects of methylphenidate in stimulant drug‐naïve boys with ADHD II – broader executive and non‐executive domains
Rhodes, S. M., Coghill, D. R., & Matthews, K. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01633.x · Cited by 112
SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110
Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
Faraone, S. V., Biederman, J., Spencer, T., Michelson, D., Adler, L., Reimherr, F., & Glatt, S. J. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-16 · Cited by 108
Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans
Cropley, V. L., Innis, R. B., Nathan, P. J., Brown, A. K., Sangare, J. L., Lerner, A., Ryu, Y. H., Sprague, K. E., Pike, V. W., & Fujita, M. (2008) · Synapse · doi:10.1002/syn.20506 · Cited by 104
Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD
Leo, D., Sorrentino, E., Volpicelli, F., Eyman, M., Greco, D., Viggiano, D., di Porzio, U., & Perrone-Capano, C. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.009 · Cited by 103
Loss of autoreceptor function in dopaminergic neurons from dopamine D-2 receptor deficient mice
Mercuri, N., Saiardi, A., Bonci, A., Picetti, R., Calabresi, P., Bernardi, G., & Borrelli, E. (1997) · UCL Discovery (University College London) · Cited by 101
Relative lack of cognitive effects of methylphenidate in elderly male volunteers
Clark, L., Aron, A. R., Dowson, J. H., Sahakian, B. J., Turner, D. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1457-3 · Cited by 94
ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow
Lou, H. C., Rosa‐Neto, P., Pryds, O. A., Karrebæk, H., Lunding, J. M. C., Cumming, P. D., & GJEDDE, A. H. (2004) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162204000313 · Cited by 90
Measurement of Methylphenidate-Induced Change in Extrastriatal Dopamine Concentration using [11C]FLB 457 PET
Montgomery, A. J., Asselin, M.-C., Farde, L., & Grasby, P. M. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600339 · Cited by 85
Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD
Krause, J., la Fougere, C., Krause, K.-H., Ackenheil, M., & Dresel, S. H. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0602-x · Cited by 84
Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: A 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study
Ludolph, A. G., Kassubek, J., Schmeck, K., Glaser, C., Wunderlich, A., Buck, A. K., Reske, S. N., Fegert, J. M., & Mottaghy, F. M. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.02.025 · Cited by 83
Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum
Červenka, S., Bäckman, L., Cselényi, Z., Halldin, C., & Farde, L. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.063 · Cited by 80
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2
Seneca, N. M., Gulyás, B. Z., Varrone, A., Schou, M., Airaksinen, A. J., Tauscher, J. T., Vandenhende, F., Kielbasa, W., Farde, L., Innis, R. B., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0483-3 · Cited by 78
A double-blind trial of bupropion in children with attention deficit disorder.
Casat, C. D., Pleasants, D. Z., & Fleet, J. V. W. (1987) · PubMed · Cited by 77
Is increased D2 receptor availability associated with response to stimulant medication in ADHD
Ilgin, N., Şenol, S., Gücüyener, K., Gökçora, N., Atavci, S., & Şener, Ş. (2001) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162201001384 · Cited by 75
Comment on “Modafinil Shifts Human Locus Coeruleus to Low-Tonic, High-Phasic Activity During Functional MRI” and “Homeostatic Sleep Pressure and Responses to Sustained Attention in the Suprachiasmatic Area”
Astafiev, S. V., Snyder, A. Z., Shulman, G. L., & Corbetta, M. (2010) · Science · doi:10.1126/science.1177200 · Cited by 72
Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study
Takahashi, H., Fujimura, Y., Hayashi, M., Takano, H., Kato, M., Okubo, Y., Kanno, I., Ito, H., & Suhara, T. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008103 · Cited by 71
Stimulant medications: how to minimize their reinforcing effects?
VOLKOW, N. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.359 · Cited by 70
Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder
Hesse, S., Ballaschke, O., Barthel, H., & Sabri, O. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.01.002 · Cited by 70
Psychostimulants induce low-frequency oscillations in the firing activity of dopamine neurons
Shi, W.-X., Pun, C.-L., & Zhou, Y. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300534 · Cited by 66
In vivo assessment of basal and drug‐induced dopamine release in cortical and subcortical regions of the anesthetized primate
Moghaddam, B., Berridge, C. W., Goldman‐Rakic, P. S., Bunney, B. S., & Roth, R. H. (1993) · Synapse · doi:10.1002/syn.890130304 · Cited by 64
Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder.
Forssberg, H., Fernell, E., Waters, N., Waters, N., & Tedroff, J. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-40 · Cited by 64
Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers
Winder-Rhodes, S., Chamberlain, S. R., Idris, M. I., Robbins, T. W., Sahakian, B. J., & Müller, U. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109105899 · Cited by 60
Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis
Kuczenski, R. T., & Segal, D. S. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90106-5 · Cited by 58
The Neurobiology of Attention-Deficit/Hyperactivity Disorder
Chamberlain, S. R., Robbins, T. W., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.009 · Cited by 58
Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder
Larisch, R., Sitte, W., Antke, C., Nikolaus, S., Franz, M., Tress, W., & M??ller, H.-W. (2006) · Nuclear Medicine Communications · doi:10.1097/00006231-200603000-00010 · Cited by 58
Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder
la Fougère, C., Krause, J., Krause, K.-H., Josef Gildehaus, F., Hacker, M., Koch, W., Hahn, K., Tatsch, K., & Dresel, S. (2006) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000230077.48480.68 · Cited by 57 · cited 2×
“La Fougere et al. 2006 (37) Patients with high striatal DAT availability responded better to therapy with MPH than those with low DAT availability.”
Background
The effect of methylphenidate on information processing
Naylor, H., Halliday, R., & Callaway, E. (1985) · Psychopharmacology · doi:10.1007/bf00431690 · Cited by 57
Methylphenidate‐Evoked Potentiation of Extracellular Dopamine in the Brain of Adolescents with Premature Birth: Correlation with Attentional Deficit
NETO, P. R., LOU, H., CUMMING, P., PRYDS, O., & GJEDDE, A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04184.x · Cited by 54
Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele
Krause, J., Dresel, S. H. J., Krause, K., la Fougère, C., Zill, P., & Ackenheil, M. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500518444 · Cited by 47
Lack of deleterious effects of buspirone on cognition in healthy male volunteers
Chamberlain, S. R., Müller, U., Deakin, J., Corlett, P., Dowson, J. H., Cardinal, R. N., Aitken, M. R. F., Robbins, T. W., & Sahakian, B. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881107068066 · Cited by 47
Dopamine Transporter in Attention-Deficit Hyperactivity Disorder Normalizes After Cessation of Methylphenidate
FERON, F. J. M., Hendriksen, J. G. M., van Kroonenburgh, M. J. P. G., Blom-Coenjaerts, C., Kessels, A. G. H., Jolles, J., Weber, W. E. J., & Vles, J. S. H. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.04.008 · Cited by 38
New-generation radiotracers for nAChR and NET
Ding, Y., & Fowler, J. S. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.04.017 · Cited by 34
Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder - a single Photon Emission Computed Tomography with [Tc99m]TRODAT-1 study
Szobot, C. M., Shih, M. C., Schaefer, T., Júnior, N., Hoexter, M. Q., Fu, Y. K., Pechansky, F., Bressan, R. A., & Rohde, L. A. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.050 · Cited by 33
Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2
Takano, A., Varrone, A., Gulyás, B. Z., Karlsson, P., Tauscher, J. T., & Halldin, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.040 · Cited by 31
5.1 From Behavior to Cognition: Functions of Mesostriatal, Mesolimbic, and Mesocortical Dopamine Systems
Robbins, T. W. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0014 · Cited by 15
Regulation of the Neurotransmitter Norepinephrine
Axelrod, J. (1974) · Profiles in Science · Cited by 12
Noise Stress Impairs Prefrontal Cortical Cognitive Function in Monkeys: Evidence for a Hyperdopaminergic Mechanism
Arnsten, A. F. T., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.362 · Cited by 6

Flagged first, then by citations

4 of the 129 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Draganski, 2008, Evidence for segregated and integrative connectivity patterns in the human basal ganglia, J Neurosci, 28, 7143, 10.1523/JNEUROSCI.1486-08.2008 · DOI

Sorted by citations

Fractionating impulsivity: neuropsychiatric implications
Dalley, J. W., & Robbins, T. W. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.8 · Cited by 607
New developments in human neurocognition: clinical, genetic and brain imaging correlates of impulsivity and compulsivity
Fineberg, N. A., Chamberlain, S. R., Goudriaan, A. E., Stein, D. J., Vanderschuren, L. J. M. J., Gillan, C. M., Shekar, S., Gorwood, P. A. P. M., Voon, V., Morein-Zamir, S., et al. (2014) · CNS Spectrums · doi:10.1017/s1092852913000801 · Cited by 488
Self-citation
Spontaneous eye blink rate as predictor of dopamine-related cognitive function—A review
Jongkees, B. J., & Colzato, L. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.020 · Cited by 300
Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
Dunn, G. A., Nigg, J. T., & Sullivan, E. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.005 · Cited by 299
The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): What every clinician should know
Cortese, S. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.01.009 · Cited by 335

See all 685

Authors: del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W.
Affiliations: University of Cambridge (GB)
ORCID: Chamberlain, Samuel R.
Sahakian, Barbara J.
Robbins, Trevor W.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2011-06
Volume: 69
Issue: 12
Pages: e145-e157
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2011.02.036
OpenAlex: W2025431637
Cited by: 685
References: 129
Citations by year: 2026: 61 · 2025: 65 · 2024: 57 · 2023: 49 · 2022: 51 · 2021: 46 · 2020: 43 · 2019: 41 · 2018: 36 · 2017: 31 · 2016: 32 · 2015: 45 · 2014: 44 · 2013: 32 · 2012: 43
FWCI: 5.37
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (submittedVersion)
Funders: Gates Cambridge Trust
Wellcome Trust
Medical Research Council
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords: attention deficit hyperactivity disorder, dopamine, norepinephrine, catecholamines, executive function, corticostriatal circuits, prefrontal cortex, striatum, positron emission tomography, methylphenidate, d-amphetamine, atomoxetine, neuromodulation, ADHD treatment
MeSH terms: Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Brain Mapping, Cerebral Cortex, Corpus Striatum, Dopamine, Humans, Neural Pathways, Norepinephrine, Prefrontal Cortex, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks